Company Overview
Snapshot
Founded in August 2021 by Nava Barit Ben-David, Renalyte Medical operates with 1–10 employees. The company is currently in the R&D product stage, focusing on developing its fully implantable renal-assist device.
Business overview
Renalyte Medical is innovating kidney care by developing a fully implantable renal-assist device designed to replace traditional dialysis. This technology aims to provide autonomous, 24/7 therapy, restoring patient freedom and reducing healthcare burdens. The company's platform is engineered for scalable evolution, starting with continuous hemofiltration and progressing toward fully implantable hemodiafiltration in future versions. Renalyte Medical operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics, serving healthcare providers and patients.
Log in to access full profile ›Company Intelligence Q&A
- What is Renalyte Medical's core product?
- Renalyte Medical is developing the first and only fully implantable renal-assist device designed to replace traditional dialysis with autonomous, 24/7 therapy.
- When was Renalyte Medical founded?
- Renalyte Medical was founded in August 2021.
- Who is the founder of Renalyte Medical?
- Nava Barit Ben-David is the Co-founder & CEO of Renalyte Medical.
- What stage is Renalyte Medical's product development in?
- Renalyte Medical's product is currently in the R&D stage, focusing on developing its fully implantable renal-assist device. The company aims to provide autonomous, 24/7 therapy to replace traditional dialysis.
- What is the primary goal of Renalyte Medical's technology?
- The primary goal of Renalyte Medical's technology is to restore patient freedom, reduce healthcare burden, and provide a game-changing solution for kidney care by reimagining renal care with patient liberation at its core.